Bacteria in Dental Plaque and Atheroma Plaque

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorIstanbul Saglik Bilimleri University

About this trial

Periodontitis is considered a focus of infection where oral bacteria, bacterial by-products or inflammatory mediators can interact with other parts of the organism via the blood. Periodontal pathogen components such as DNA, RNA or specific antigens of P. gingivalis, Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Treponema denticola (T. denticola), Fusobacterium nucleatum (F. nucleatum) or Campylobacter rectus have been isolated from different tissues such as atheroma plaques, placenta, amniotic sac and respiratory tract. It has been reported that periodontitis may contribute to endothelial dysfunction leading to the formation of atherosclerosis.

Eligibility criteria

Qualifiers

Diagnosed with endarterectomy

Not receiving chemotherapy

Not having received this treatment before

Disqualifiers

Having systemic infection

Patients with severe heart disease

Trial design

Treatments tested in this trial

  • atheroma plaque
  • dental plaque

Treatment groups

60 Participants
are divided into 1 treatment group